Page 2,450«..1020..2,4492,4502,4512,452..2,4602,470..»

Tiny molecules preserve stem cells: Research shows what makes constant plant growth possible

Posted: January 23, 2013 at 1:47 am

Jan. 22, 2013 Human life is dependent on the constant growth of plants, and it is the job of stem cells to see to it that this occurs. They are found at the tips of the shoots and roots, the so-called meristems. Stem cells can transform themselves into other types of cells and develop new organs, such as leaves, fruits, and twigs, throughout the entire lifespan of the plant. However, in order for the plant to continue growing and developing organs, several cells at the tips of the shoots and roots have to remain stem cells. In order to ensure that this is the case, the cells need signals to help them identify their position in the plant and trigger the appropriate developmental program.

A team led by Prof. Dr. Thomas Laux from the Institute of Biology III of the University of Freiburg has succeeded in confirming that plants need a micro-RNA at the tip of their shoots to prevent all of the stem cells from transforming themselves into other cell types. The Freiburg researchers used thale cress as a model organism for their studies. Their findings have now been published in the journal Developmental Cell.

Micro-RNAs are very small molecules of ribonucleic acid (RNA) that do not encode any proteins themselves but rather prevent proteins from being generated from other RNAs. Thanks to their diminutive size, micro-RNAs can move from one cell to the next in plants.

Scientists are already familiar with one micro-RNA that informs meristem cells that they should specialize. However, this micro-RNA needs to be neutralized in the area where stem cells need to be preserved. Thomas Laux, member of the Cluster of Excellence BIOSS Centre for Biological Signalling Studies, has now succeeded in demonstrating that there is a second micro-RNA that serves precisely this function, thus preventing the stem cells from transforming.

The newly discovered micro-RNA, the stem cell preserver, is only produced in one particular cell layer, the epidermis of the tip of the shoot. The micro-RNA only reaches several underlying layers of cells near its home in the epidermis, all of which become stem cells. The more distant areas do not receive enough stem cell preservers, and the cells there transform themselves into other cell types. In this way, the plant can preserve the stem cells at the tip of its shoots and thus develop leaves, blossoms, or fruits regardless of environmental influences.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Albert-Ludwigs-Universitt Freiburg.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

See more here:
Tiny molecules preserve stem cells: Research shows what makes constant plant growth possible

Posted in Stem Cells | Comments Off on Tiny molecules preserve stem cells: Research shows what makes constant plant growth possible

Top Three Regenerative Medicine Companies Targeting Ischemic Conditions

Posted: January 23, 2013 at 1:47 am

As we discussed in our first article on elite regenerative medicine companies, there are several methodologies to delineating the cream of the crop. In this exercise, we will take a look at the impact that regenerative medicine technologies can have on ischemic conditions where tissue in the heart, brain, organs or limbs are damaged as a result of restricted blood flow and identify some of the most innovative companies that have a strong upside based on the products and technologies they are developing, stage of development, and current valuations.

Ischemic conditions are expansive, covering common conditions such as stroke, heart disease and peripheral vascular disease (which in severe cases can result in critical limb ischemia, requiring amputation of digits or limbs). The economic impact of these types of conditions is also substantial. Research by the American Heart Association indicates that cardiovascular disease (most of which is ischemic in nature) comprises more than $300 billion in healthcare related expenses annually, accounting for more than 17% of total healthcare related expenses in the U.S. Furthermore, these conditions impose a huge quality of life burden for patients and their families, and therefore are areas of great unmet medical need.

From a company and investor perspective, they represent multi-billion-dollar opportunities. Cumulatively, hundreds of millions of people are affected globally, but traditional medicines and clinical treatments provide little benefit. Regenerative medicine technologies represent new options that could yield a new age of therapies and viable solutions for patients that presently have very few, if any, options.

In our initial article, Cytomedix, Inc. (OTCQX:CMXI) was omitted from the top five because of the broad scope of credentials defining companies with obvious headroom for growth. Within the parameters of ischemia-related treatments, however, the Gaithersburg, Maryland-based developer of biologically active regenerative therapies deserves a strong mention.

Cytomedix is developing platelet technologies for orthopedics and wound care and a pipeline of autologous (patient-derived) stem cell therapies for tissue repair. The company is already generating revenue through its AutoloGel System, a platelet rich plasma (PRP) producing device for exuding wounds, and its Angel Whole Blood Separation System, a blood processing device for separating whole blood into red cells, platelet poor plasma (PPP) and PRP for use in surgical and orthopedic settings. For the third quarter of 2012, total revenues increased 15% to $1.76 million from $1.53 million in the year prior quarter.

Honing in on the ischemic conditions, through the acquisition of Aldagen in February at a bargain price of $16 million in stock (plus additional shares upon milestones being met), Cytomedix gained control of Aldagens proprietary ALDH bright cell (ALDHbr) technology and finally made the transition from just a wound care company to cement its position as a leading developer of a promising new therapy to treat patients that have recently suffered a stroke.

The ALDHbr technology is used to isolate biologically active stem cells which have previously shown the potential to promote cell and tissue regeneration in preclinical studies. The cells are isolated from the patients own bone marrow, shipped to the company for subsequent expansion, and are then reinfused into the patient roughly 3 weeks later. A 100-patient Phase 2 trial for the treatment of ischemic stroke using ALDHbr Bright Cells derived from a patients own bone marrow is underway that will involve patients from 12 to 15 sites in the United States. Safety data from the first 10 patients in the Phase II RECOVER-Stroke study of ALD-401 were recently presented at the World Stroke Congress in Brazil showing a solid safety profile.

The clinical trials aim to build upon promising laboratory research. Mice treated with ALD-401 two weeks after an induced stroke demonstrated nearly four-fold improvement in motor function compared to controls. Further, stark improvements were seen in ALD-401 slowing decreases in brain volume and the reversal of decline in stroke-induced cell viability. Additional studies with ALD-401 in animal models showed perfusion (blood flow) levels returning to normal after four weeks in stroke-induced subjects receiving the ALDHbr cell treatment while untreated controls remained impaired.

This study is only one of several clinical trials being conducted to test Cytomedixs ALDHbr technology. ALD-201 has completed a Phase I clinical trial testing its safety as a therapeutic candidate for ischemic heart failure. The 20-patient trial showed ALD-201 to be well-tolerated and produced a statistically significant reduction in ischemia as well as improvement in MaxVO2, a measure of the bodys ability to take up oxygen during exercise, in patients receiving the ALDHbr therapy as compared to a placebo group.

In a 21-patient Phase 1/2 clinical trial on ALD-301 testing critical limb ischemia with no revascularization options, the treatment was again well-tolerated with data indicating improved blood flow. Patients with this condition face a 35% risk of limb amputation, but 10 of the 11 patients (91%) treated with ALD-301 required no such procedure.

Original post:
Top Three Regenerative Medicine Companies Targeting Ischemic Conditions

Posted in Regenerative Medicine | Comments Off on Top Three Regenerative Medicine Companies Targeting Ischemic Conditions

Springhill Medical Group-What is Stem Cell Therapy? – Video

Posted: January 21, 2013 at 9:44 pm


Springhill Medical Group-What is Stem Cell Therapy?
springhillmedgroup.com We have been hearing about this stem cell lately but does everyone know about what this really is? According to medical researchers, stem cell treatments have the potential to change the face of human disease and alleviate suffering. There are already many stem treatments nowadays but they are not usually used because they tend to be experimental and they are very expensive. Medical researchers foresee being able to use technologies derived from stem cell research to treat cancer, spinal cord injuries, and muscle damage, amongst a number of other diseases and impairments. This stem cell therapy is established in order to treat disease or injury by introducing new adult stem cells into damaged tissue. Stem cell therapy is an intervention strategy. The good thing about stem cell is that there are minimal risk of rejection and side effects. They have the ability to self-renew and give rise to subsequent generations with variable degrees of differentiation capacities. They also offer significant potential for generation of tissues that can potentially replace diseased and damaged areas in the body. It has been said that there are already a number of stem-cell therapies that exist but most are costly. But bone-marrow transplantation, to some extent has exemption.

By: Madeline Brunner

See the article here:
Springhill Medical Group-What is Stem Cell Therapy? - Video

Posted in Stem Cell Videos | Comments Off on Springhill Medical Group-What is Stem Cell Therapy? – Video

Stem cells… what is their potential? Evidence from animal models – Video

Posted: January 21, 2013 at 9:44 pm


Stem cells... what is their potential? Evidence from animal models
http://www.stemcells.arthritistreatment.com Stem cells can differentiate into different cell lines due to various capabilities. The first report that stem cells could possibly heal cartilage came from a study done with New Zealand rabbits. Full thickness cartilage defects were treated with collagen sponges soaked with mesenchymal stem cells. The stem cells differentiated into chondrocytes. In another study published in the BMC Musculoskeletal Disorders journal, , labeled autologous adult stem cells were injected into the joints of arthritic donkeys. Significant improvement was noted in clinical as well as x-ray changes. Histopathological improvements were also seen. Importantly, injected stem cells were incorporated into the cartilage of the injected joint. Challenges remain though. What is an adequate number of cells needed to home in on the area of damage? What is the long term safety? What is the durability of the benefit? http

By: Nathan Wei

Here is the original post:
Stem cells... what is their potential? Evidence from animal models - Video

Posted in Stem Cell Videos | Comments Off on Stem cells… what is their potential? Evidence from animal models – Video

What’s being done in the lab about stem cells.mp4 – Video

Posted: January 21, 2013 at 9:44 pm


What #39;s being done in the lab about stem cells.mp4
http://www.stemcellsarthritistreatment.com Laboratory studies of stem cells enable scientists to learn about the cells #39; essential properties and what makes them different from specialized cell types. Scientists are already using stem cells in the laboratory to screen new drugs and to develop model systems to study normal growth and identify the causes of birth defects. Research on stem cells continues to advance knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Stem cell research is one of the most fascinating areas of contemporary biology. However, research on stem cells raises scientific questions as rapidly as it generates new discoveries. http

By: Nathan Wei

Read the rest here:
What's being done in the lab about stem cells.mp4 - Video

Posted in Stem Cell Videos | Comments Off on What’s being done in the lab about stem cells.mp4 – Video

Stem cells arthritis treatment- The Blackboard and Dennis Keener.mp4 – Video

Posted: January 21, 2013 at 9:44 pm


Stem cells arthritis treatment- The Blackboard and Dennis Keener.mp4
http://www.stemcellsarthritistreatment.com The use of autologous stem cells to treat osteoarthritis is still a controversial area. Does it really work? For the most part we have only anecdotal evidence... but some anecdotes are pretty powerful. http

By: Nathan Wei

Read more:
Stem cells arthritis treatment- The Blackboard and Dennis Keener.mp4 - Video

Posted in Stem Cell Videos | Comments Off on Stem cells arthritis treatment- The Blackboard and Dennis Keener.mp4 – Video

Another Update on Spirulina – Video

Posted: January 21, 2013 at 9:44 pm


Another Update on Spirulina
Subscribe for free to Dr. Greger #39;s videos at bit.ly DESCRIPTION: Potential neurotoxicity is another concern regarding spirulina supplements. Have a question about this video? Leave it in the comment section at nutritionfacts.org and I #39;ll try to answer it! For some context, please also check out my associated blog posts Breast Cancer Stem Cells vs. Broccoli (nutritionfacts.org and The Best Foods: Test Your Nutrition Knowledge (nutritionfacts.org Have a question for Dr. Greger about this video? Leave it in the comment section at nutritionfacts.org and he #39;ll try to answer it!

By: NutritionFactsOrg

Read more:
Another Update on Spirulina - Video

Posted in Stem Cell Videos | Comments Off on Another Update on Spirulina – Video

Adipose stem Cell Harvest for Fat Stem Cell Treatment in Thailand Autologous Harvesting – Video

Posted: January 21, 2013 at 9:44 pm


Adipose stem Cell Harvest for Fat Stem Cell Treatment in Thailand Autologous Harvesting
Adipose stem cells (ASCs) are an attractive and abundant stem cell source with therapeutic applicability in repair and regeneration. thaimedicalvacation.com This is video about hoe doctors in Thailand harvest adipose tissue for combination treatment with bone marrow aspirate for stem cell therapy in Bangkok. adipose tissue stem cell treatments to cartilage stem cells,blood stem cell,bone stem cell,epithelial stem cells,adipose stem cell differentiation,adipose stem cell culture.to learn more please contact us today. for more information about cosmetic surgery in Thailand or one of the dozens of other surgical and non-surgical solutions we offer please contact us email: help@thaimedicalvacation.com SKYPE: Thai.MedicalVacation Telephone THAILAND +66 02 402 6566 AUSTRALIA: 02 8006 1094 EUROPE: +44 20 7979 1977 NORTH AMERICA: 1-888-497-3485 USA LOCAL: 1-347-450-THAI

By: thaimedicalvacation

Link:
Adipose stem Cell Harvest for Fat Stem Cell Treatment in Thailand Autologous Harvesting - Video

Posted in Stem Cell Videos | Comments Off on Adipose stem Cell Harvest for Fat Stem Cell Treatment in Thailand Autologous Harvesting – Video

Fastway News – Stemade Biotech launches Ludhiana’s first dental stem cell banking facility – Video

Posted: January 21, 2013 at 9:44 pm


Fastway News - Stemade Biotech launches Ludhiana #39;s first dental stem cell banking facility
Stemade Biotech has partnered with Dr. Prof. Vivek Saggar #39;s -- #39;Dental Care and Cure Centre #39; and Dr. Prof. Vikas Jindal #39;s - #39;Jindal Smile Clinic #39; to provide dental stem cell banking service by launching Stemade Connect Clinics (SCC). Stem cells have a defining property to self -- regenerate which can be used to treat serious ailments. Unlike Bone marrow stem cells, extracting dental cells is a non-invasive procedure. Dental pulp contains stem cells, known as dental pulp stem cells. The finest Dental Pulp Stem Cells are found in the baby teeth or milk teeth. Dental stem cells can generate solid structures such as bone, new dental tissue, cartilage and muscle.

By: Infinity Public Relations

See more here:
Fastway News - Stemade Biotech launches Ludhiana's first dental stem cell banking facility - Video

Posted in Stem Cell Videos | Comments Off on Fastway News – Stemade Biotech launches Ludhiana’s first dental stem cell banking facility – Video

Dr. Ioannis Papasotiriou MD, Academy of Comprehensive Integrative Medicine – Video

Posted: January 21, 2013 at 6:46 pm


Dr. Ioannis Papasotiriou MD, Academy of Comprehensive Integrative Medicine
Testing of Circulating Tumor Cells Cancer Stem-cell-like Cells Offers New Options to Cancer Therapy. October 2012 ,ACIMconnect

By: RGCCLTD

See the original post here:
Dr. Ioannis Papasotiriou MD, Academy of Comprehensive Integrative Medicine - Video

Posted in Integrative Medicine | Comments Off on Dr. Ioannis Papasotiriou MD, Academy of Comprehensive Integrative Medicine – Video

Page 2,450«..1020..2,4492,4502,4512,452..2,4602,470..»